eFFECTOR Therapeutics, Inc.
EFTRCIK 0001828522 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Feb 21, 2024
Unique insiders
6
Showing
6 of 6
Page 1
Top insiders
Most active reporters at eFFECTOR Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Byrnes Michael | Officer | 1 |
| Ehrlich Christopher B | Director | 1 |
| Gallagher Brian M. Jr. | Director | 1 |
| Klencke Barbara | Director | 1 |
| Loewy Caroline M | Director | 1 |
| WORLAND STEPHEN T | OfficerDirector | 1 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 21, 2024 | WORLAND STEPHEN T Chief Executive Officer · Director | Holdings only | — | — | — | |
| Feb 21, 2024 | Byrnes Michael Chief Financial Officer | Holdings only | — | — | — | |
| Feb 21, 2024 | Gallagher Brian M. Jr. Director | Holdings only | — | — | — | |
| Feb 21, 2024 | Klencke Barbara Director | Holdings only | — | — | — | |
| Feb 21, 2024 | Ehrlich Christopher B Director | Holdings only | — | — | — | |
| Feb 21, 2024 | Loewy Caroline M Director | Holdings only | — | — | — |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.